Insights

Gathering insights about LIDDS …

Similar companies to LIDDS

LIDDS Tech Stack

LIDDS uses 8 technology products and services including Font Awesome, Google Font API, jQuery UI, and more. Explore LIDDS 's tech stack below.

Font Awesome
Font Scripts
Google Font API
Font Scripts
jQuery UI
Javascript Libraries
Modernizr
Javascript Libraries
jQuery
Javascript Libraries
Yoast SEO
Search Engines
Google Tag Manager
Tag Management
Apache HTTP Server
Web Servers

Media & News

Lidds Ab acquired Noviga Research AB on Jan 29th '24.
UPPSALA, SWEDEN - LIDDS AB (publ) announced today that the company has signed an agreement to acquire Noviga Research AB, a Swedish biotechnology company focused on the development of new cancer drugs.
Jan 29, 2024 | www.marketscreener.com
Lidds Ab hired Jenni Björnulfson as CEO on Nov 28th '23.
LIDDS AB (publ) announced that the Board of Directors has appointed the drug delivery company's CFO Jenni Björnulfson as the new CEO.
Nov 28, 2023 | www.marketscreener.com
Lidds Ab hired Matthew Lindon as Chief Executive Officer on Aug 1st '23.
LIDDS appoints Matthew Lindon as acting CEO.
Jul 30, 2023 | liddspharma.com
Lidds Ab hired Annette Møldrup as Head of Clinical Development on Jul 7th '22.
LIDDS AB (publ) announces today that the company has recruited Annette Møldrup as Chief Business Development Officer and Kia Bengtsson as Head of Clinical Development.
Jul 06, 2022 | liddspharma.com
Lidds Ab hired Matthew Lindon as Chief Scientific Officer on Dec 17th '21.
LIDDS AB (publ) announced today that Matthew Lindon has been appointed Chief Scientific Officer (CSO) of LIDDS AB.
Dec 20, 2021 | www.globenewswire.com
Lidds Ab hired Johan Harmenberg as Chief Medical Officer on Nov 15th '21.
LIDDS AB (publ) announced today that Johan Harmenberg has been appointed Chief Medical Officer (CMO) of LIDDS AB.
Nov 15, 2021 | www.globenewswire.com
Lidds Ab is developing oncology product based on the NanoZolid technology on Mar 2nd '21.
LIDDS AB (publ) announced today that an agreement has been signed with Johnson & Johnson Enterprise Innovation Inc. to develop an oncology product based on the NanoZolid ® technology for an undisclosed indication.
Mar 02, 2021 | www.globenewswire.com

LIDDS 's Email Address Formats

LIDDS uses at least 1 format(s):

LIDDS Email Formats	Example	Percentage
First.Last@liddspharma.com	John.Doe@liddspharma.com	47%
First.MiddleLast@liddspharma.com	John.MichaelDoe@liddspharma.com	3%
First.Last@liddspharma.com	John.Doe@liddspharma.com	47%
First.MiddleLast@liddspharma.com	John.MichaelDoe@liddspharma.com	3%

Frequently Asked Questions

Where is LIDDS 's headquarters located?

LIDDS 's main headquarters is located at Virdings Allé 32B Uppsala, Region Uppsala 75450 SE. The company has employees across 1 continents, including Europe.

What is LIDDS 's official website and social media links?

LIDDS 's official website is liddspharma.com and has social profiles on LinkedIn.

How much revenue does LIDDS generate?

As of November 2024, LIDDS 's annual revenue reached $750K.

What is LIDDS 's SIC code NAICS code?

LIDDS 's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does LIDDS have currently?

As of November 2024, LIDDS has approximately 2 employees across 1 continents, including Europe. Key team members include Chief Executive Officer: A. M.Chief Financial Officer: J. B.Chief Medical Officer: R. B.. Explore LIDDS 's employee directory with LeadIQ.

What industry does LIDDS belong to?

LIDDS operates in the Biotechnology Research industry.

What technology does LIDDS use?

LIDDS 's tech stack includes Font AwesomeGoogle Font APIjQuery UIModernizrjQueryYoast SEOGoogle Tag ManagerApache HTTP Server.

What is LIDDS 's email format?

LIDDS 's email format typically follows the pattern of . Find more LIDDS email formats with LeadIQ.

How much funding has LIDDS raised to date?

As of November 2024, LIDDS has raised $4.4M in funding. The last funding round occurred on Feb 22, 2022 for $4.4M.

LIDDS

Biotechnology ResearchRegion Uppsala, Sweden2-10 Employees

LIDDS is a Swedish drug delivery company based on the proprietary technology NanoZolid®. With NanoZolid®, LIDDS can formulate drugs for local administration, with a maintained and controlled release for up to six months.

Company Overview

Headquarters: Virdings Allé 32B Uppsala, Region Uppsala 75450 SE
Website: liddspharma.com
SIC Code: 8733 - Noncommercial Research Organizations
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees: 2-10

Media & News

Funding & Financials

$4.4M
LIDDS has raised a total of $4.4M of funding over 1 rounds. Their latest funding round was raised on Feb 22, 2022 in the amount of $4.4M.
$10M
LIDDS 's revenue is in the range of $10M

Funding & Financials

$4.4M
LIDDS has raised a total of $4.4M of funding over 1 rounds. Their latest funding round was raised on Feb 22, 2022 in the amount of $4.4M.
$10M
LIDDS 's revenue is in the range of $10M

Company Leadership

A. M.
Chief Executive Officer
✕
Access Insights for LIDDS and Millions of Other Companies
Sign up for full access to LIDDS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for LIDDS and Millions of Other Companies
Sign up for full access to LIDDS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. B.
Chief Financial Officer
✕
Access Insights for LIDDS and Millions of Other Companies
Sign up for full access to LIDDS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for LIDDS and Millions of Other Companies
Sign up for full access to LIDDS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
R. B.
Chief Medical Officer
✕
Access Insights for LIDDS and Millions of Other Companies
Sign up for full access to LIDDS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for LIDDS and Millions of Other Companies
Sign up for full access to LIDDS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
E. D. B.
Head Of Preclinical R&d And Translational Medicine
✕
Access Insights for LIDDS and Millions of Other Companies
Sign up for full access to LIDDS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for LIDDS and Millions of Other Companies
Sign up for full access to LIDDS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
S. G.
Head Of Cmc & Qa
✕
Access Insights for LIDDS and Millions of Other Companies
Sign up for full access to LIDDS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for LIDDS and Millions of Other Companies
Sign up for full access to LIDDS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

S. G.
Head Of Cmc & Qa
✕
Access Insights for LIDDS and Millions of Other Companies
Sign up for full access to LIDDS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for LIDDS and Millions of Other Companies
Sign up for full access to LIDDS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to LIDDS

Allarity Therapeutics

Pharvaris

Scandion Oncology

CELLINK

LIDDS Tech Stack

Media & News

Lidds Ab acquired Noviga Research AB on Jan 29th '24.

Lidds Ab hired Jenni Björnulfson as CEO on Nov 28th '23.

Lidds Ab hired Matthew Lindon as Chief Executive Officer on Aug 1st '23.

Lidds Ab hired Annette Møldrup as Head of Clinical Development on Jul 7th '22.

Lidds Ab hired Matthew Lindon as Chief Scientific Officer on Dec 17th '21.

Lidds Ab hired Johan Harmenberg as Chief Medical Officer on Nov 15th '21.

Lidds Ab is developing oncology product based on the NanoZolid technology on Mar 2nd '21.

LIDDS 's Email Address Formats

Frequently Asked Questions

Where is LIDDS 's headquarters located?

What is LIDDS 's official website and social media links?

How much revenue does LIDDS generate?

What is LIDDS 's SIC code NAICS code?

How many employees does LIDDS have currently?

What industry does LIDDS belong to?

What technology does LIDDS use?

What is LIDDS 's email format?

How much funding has LIDDS raised to date?

LIDDS

Company Overview

Media & News

Lidds Ab acquired Noviga Research AB on Jan 29th '24.

Lidds Ab hired Jenni Björnulfson as CEO on Nov 28th '23.

Lidds Ab hired Matthew Lindon as Chief Executive Officer on Aug 1st '23.

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?